However, CLDN17 expression was associated with HCC occurrence and metastasis (P = 0.001 < 0.01), histological grade (P = 0.001 < 0.01) and TNM stage (P = 0.001 < 0.01) (Table 1). Here, CLDN17 is linked to hepatocellular carcinoma.